Method and kit for detecting AFB1 based on signal enhanced distance sensing
By combining AFB1-BSA solid phase carrier, silver nanoparticle-IgM antibody-PEG complex and platinum-copper bimetallic alloy nanozyme on a microfluidic chip, the signal-enhanced distance sensing detection of AFB1 is achieved, solving the existing solutions The low sensitivity problem caused by signal suppression output in the technology realizes high-sensitivity trace AFB1 detection and is low-cost and portable.
Patent Information
- Application Number
- CN202411026607.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-12
AI Technical Summary
The existing AFB1 detection method has a signal suppression output method, which leads to low sensitivity and is difficult to detect trace AFB1 quantitatively through the naked eye. The equipment is complex and expensive, which limits its application range.
Using a signal-enhanced distance sensing detection method, a solid phase support, silver nanoparticle-IgM antibody-PEG complex and platinum-copper bimetallic alloy nanoenzyme coated with AFB1-BSA, was used to react in the microflow through enzyme catalytic reaction. The dye moving distance and AFB1 content are proportional to the dye content on the control chip, and the flip signal suppression type is a signal enhanced output.
It significantly improves the sensitivity of AFB1 detection, realizes the naked eye quantitative detection of trace AFB1, with a detection limit of 9pg/mL, meeting the limit requirements of different countries, and has the advantages of low cost, portability, compactness and easy operation.
Smart Images

Figure CN118937659A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biochemical sensing detection, and in particular to a method and a kit for detecting AFB1 based on signal enhancement distance sensing. Background Art
[0002] Aflatoxins are the most toxic and carcinogenic natural food contaminants discovered so far. They are mainly secondary metabolites produced by Aspergillus flavus and Aspergillus parasiticus. In 1993, the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) classified them as Class I carcinogens.
[0003] So far, more than 20 types of aflatoxins have been identified, which can be divided into group B (B1, B2) and group G (G1, G2) and other derivatives. Among them, aflatoxin B1 (AFB1) is the most toxic and has the highest content. It is widely present in food crops such as peanuts and corn, especially in foods in humid and hot areas.
[0004] With the improvement of living standards, people pay more and more attention to food safety. Countries around the world have imposed strict restrictions on the content of AFB1 in food. Therefore, it is urgent to establish a highly sensitive, highly selective, and low-cost AFB1 detection method to ensure global food safety.
[0005] At present, many mature methods have been applied to the determination of AFB1, including high performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS) and other analytical methods. These methods are accurate and sensitive, but there are still problems such as complex and time-consuming pre-treatment and the need for expensive and large-scale instruments, which greatly limits their scope of application. Immunological methods such as enzyme-linked immunosorbent assay (ELISA), immunochromatography (ICTS), photoelectrochemical immunoassay, and electrochemical immunoassay are becoming more and more popular among researchers because of their simplicity, economy, and ability to screen samples in large quantities. However, traditional ELISA usually uses natural enzymes such as horseradish peroxidase (HRP) to catalyze color substrates such as 3,3',5,5'-tetramethylbenzidine (TMB) and produce colored molecules. The content of the target is determined by the change in solution color (mostly from colored to colorless, that is, signal suppression output mode). Compared with the change from colored to colorless, the human eye is more sensitive to the change from colorless to colored. Therefore, when visually and quantitatively detecting trace amounts of small molecule hazards, the traditional signal suppression output method is difficult to distinguish them from blank samples by naked eye, which often results in lower sensitivity. Summary of the invention
[0006] In view of this, the purpose of the present invention is to provide a method and kit for detecting AFB1 based on signal enhancement distance sensing. The detection method provided by the present invention can flip the undesirable signal suppression output mode into an efficient signal enhancement output mode, greatly improving the sensitivity of AFB1 detection and realizing trace naked eye quantitative detection of AFB1.
[0007] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0008] The present invention provides a microfluidic chip detection kit for detecting AFB1, comprising a solid phase carrier coated with AFB1-BSA on the surface; AFB1 monoclonal antibody; silver nanoparticle-IgM antibody-PEG complex; H2O2; platinum-copper bimetallic alloy nanozyme; dye; microfluidic chip;
[0009] The microfluidic chip comprises a sample chamber, a reaction chamber and a strip-shaped microchannel which are connected in sequence.
[0010] Preferably, it also includes BSA solution and PBST washing solution.
[0011] The present invention provides a method for detecting AFB1 based on signal enhancement distance sensing, comprising the following steps:
[0012] Adding AFB1 monoclonal antibody and a sample solution to be tested to a solid phase carrier coated with AFB1-BSA, performing a first incubation, washing away unbound substances, and obtaining a first incubation product;
[0013] adding a silver nanoparticle-IgM antibody-PEG complex to the first incubation product, performing a second incubation, and washing away unbound substances to obtain a second incubation product;
[0014] adding the first H2O2 solution to the second incubation product to perform an etching reaction to obtain a pre-reaction solution;
[0015] The pre-reaction solution is mixed with the platinum-copper bimetallic alloy nanozyme, the resulting mixed solution is added to the sample chamber of the microfluidic chip, the second H2O2 solution and the dye are added to the reaction chamber of the microfluidic chip, the sample addition port is sealed, the microfluidic chip is shaken, the enzyme catalyzed reaction is performed, and the movement distance of the dye in the strip microchannel within a fixed time is measured;
[0016] The content of AFB1 in the sample solution to be tested is obtained according to the dye movement distance and a predetermined standard curve; the standard curve is a fitting curve of AFB1 concentration and dye movement distance.
[0017] Preferably, the method for preparing the solid phase carrier coated with AFB1-BSA comprises the following steps:
[0018] AFB1-BSA is loaded into a solid phase carrier, incubated, unbound substances are washed away, and unbound sites on the surface of the solid phase carrier are blocked to obtain a solid phase carrier with AFB1-BSA coated on the surface.
[0019] Preferably, the method for preparing the silver nanoparticle-IgM antibody-PEG complex comprises the following steps:
[0020] mixing the silver nanoparticles with the IgM antibody solution and incubating the mixture to obtain an incubation solution;
[0021] PEG was added to the obtained incubation solution to block the remaining active sites, thereby obtaining a silver nanoparticle-IgM antibody-PEG complex.
[0022] Preferably, the particle size of the platinum-copper bimetallic alloy nanozyme is 10 to 30 nm.
[0023] Preferably, the method for preparing the platinum-copper bimetallic alloy nanozyme comprises the following steps:
[0024] The soluble platinum source, the soluble copper source and the stabilizer solution are heated and mixed to obtain a mixed solution;
[0025] The mixture is mixed with a reducing agent to carry out a reduction reaction to obtain a platinum-copper bimetallic alloy nanozyme.
[0026] Preferably, the first incubation temperature is 20-40°C and the time is 20-60 min;
[0027] The second incubation temperature is 20-40°C and the time is 20-60 minutes;
[0028] The etching reaction time is 0 to 10 minutes.
[0029] Preferably, the fixing time is 10 to 30 minutes.
[0030] Preferably, the detection limit of AFB1 is 9 pg / mL, and the detection range is 0 to 50 ng / mL.
[0031] The present invention provides a method and kit for detecting AFB1 based on signal-enhanced distance sensing. The present invention combines the traditional indirect competitive enzyme-linked immunosorbent assay with the catalytic activity of active metal-regulated nanozymes, and develops a signal-enhanced catalytic gas-producing microfluidic chip distance sensing platform for visual quantitative detection of AFB1. Specifically, the present invention first constructs a solid phase carrier coated with AFB1-BSA on the surface, and then adds AFB1 monoclonal antibodies and a sample solution to be tested to the solid phase carrier. When the sample to be tested contains the target AFB1, the target AFB1 will compete with AFB1-BSA for a limited number of AFB1 monoclonal antibodies, resulting in a reduction in the AFB1 monoclonal antibodies bound to AFB1-BSA. During the washing process, since the target AFB1 and the bound AFB1 monoclonal antibodies are not bound to the surface of the solid phase carrier, they will be eluted from the surface of the solid phase carrier. After the AFB1-BSA coated on the surface of the solid phase carrier specifically binds to the AFB1 monoclonal antibody, it will combine with the silver nanoparticle (AgNPs)-IgM antibody-PEG complex (abbreviated as AgNPs-Ab-PEG). The subsequent addition of H2O2 will oxidatively etch the AgNPs and release Ag. + That is to say, the higher the content of the target AFB1 in the sample to be tested, the less AFB1 monoclonal antibody will bind to AFB1-BSA, which will further reduce the amount of AgNPs-Ab-PEG bound to AFB1 monoclonal antibody, thereby reducing the amount of Ag in the pre-reaction solution. + The lower the content, the higher the content of target AFB1 in the pre-reaction solution. + Inversely proportional.
[0032] The present invention uses a distance-based microfluidic chip to reflect Ag + Specifically, the platinum-copper bimetallic alloy nanozymes (PtCuNCs) have good catalase activity, which can catalyze the decomposition of H2O2 to produce O2, thereby increasing the pressure inside the microfluidic chip and causing the dye indicator to move along the channel inside the chip. + It will specifically bind to and inhibit the enzyme activity of PtCuNCs, resulting in its inability to catalyze the decomposition of H2O2 to produce O2, and the dye migration distance will become shorter. + The content is inversely proportional. As mentioned above, Ag + The content of Ag is also inversely proportional to the content of AFB1. Therefore, the distance the dye moves is proportional to the content of AFB1, that is, the greater the content of AFB1, the longer the distance the dye moves. +By adjusting the catalytic activity of PtCuNCs, the undesirable signal suppression mode is turned into an efficient signal enhancement output mode, which greatly improves the sensitivity of detection and enables the quantitative detection of low-concentration targets by naked eye vision. The results of the embodiment show that the detection limit of AFB1 by the method for detecting AFB1 based on signal enhancement distance sensing provided by the present invention is 9pg / mL, which meets the limit requirements of different countries.
[0033] In addition, the analytical performance of the method of the present invention is compared with the previously reported methods for detecting AFB1 such as fluorescence, electrochemiluminescence, and colorimetry. The comparison results show that the method of the present invention has certain advantages in detection range and sensitivity. Therefore, the method for detecting AFB1 based on signal enhancement distance sensing provided by the present invention successfully overcomes the shortcomings of low sensitivity of traditional detection of small molecule targets, and also has the advantages of easy carrying and rapid reading of test results; the detection method provided by the present invention has good specificity for AFB1 and is not interfered by aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), and other mycotoxins such as ochratoxin (OTA) and vomitoxin (DON).
[0034] In addition, the platinum-copper bimetallic alloy nanozyme used in the present invention can utilize the synergistic effect of the bimetal to improve the catalytic performance, can replace the traditional natural enzymes, and overcome the defects of natural enzymes that are easily inactivated, expensive, unstable catalytic activity, and easily affected by many factors such as temperature and pH in the chemical environment.
[0035] The present invention uses a distance-based microfluidic chip as a detection sensing platform, which has the advantages of low cost, fast response, integration, portability, ease of operation, and quantification by the naked eye, and has great application value in the fields of food safety. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] Figure 1 Schematic diagram of the structure of the microfluidic chip;
[0037] Figure 2 This is a physical picture of the microfluidic chip;
[0038] Figure 3 A flowchart of detecting AFB1 based on signal-enhanced distance sensing;
[0039] Figure 4 The feasibility results of detecting AFB1 based on signal-enhanced distance sensing are shown;
[0040] Figure 5 is the dye migration distance and fitting curve equation of different concentrations of AFB1;
[0041] Figure 6 is the dye migration distance and Ag + Linear plot of concentration;
[0042] Figure 7 This is the result of specific experimental detection. DETAILED DESCRIPTION
[0043] The invention provides a microfluidic chip detection kit for detecting AFB1, comprising a solid phase carrier coated with AFB1-BSA on the surface; AFB1 monoclonal antibody; silver nanoparticle-IgM antibody-PEG complex; H2O2; platinum-copper bimetallic alloy nanozyme; dye; and a microfluidic chip; the microfluidic chip comprising a sample chamber, a reaction chamber and a strip microchannel connected in sequence.
[0044] In the present invention, the AFB1-BSA is a conjugate of AFB1 and bovine serum albumin; the source of the AFB1-BSA is commercially available.
[0045] In the present invention, the solid phase carrier is preferably a 96-well plate. In the present invention, the preparation method of the solid phase carrier coated with AFB1-BSA preferably comprises the following steps:
[0046] AFB1-BSA is loaded into a solid phase carrier, incubated, unbound substances are washed off, and unbound sites on the surface of the solid phase carrier are blocked to obtain a solid phase carrier coated with AFB1-BSA on the surface. In the present invention, the amount of AFB1-BSA added is preferably 100 μL. In the present invention, the incubation temperature is preferably 4° C., and the incubation time is preferably overnight.
[0047] In the present invention, the washing solution for washing away unbound substances is preferably PBST buffer, wherein the PBST buffer contains 0.05% Tween-20 by volume, and pH = 7.4. In the present invention, the washing times for washing away unbound substances are preferably 3 times.
[0048] In the present invention, the reagent for blocking the unbound sites is preferably a PBS buffer solution containing 3wt% BSA. After blocking the unbound sites, the present invention preferably incubates again, and the temperature of the incubation is preferably 37°C, and the time is preferably 2h. After the incubation again, the present invention preferably washes, and the washing is preferably PBST washing 3 times.
[0049] In the present invention, the source of the AFB1 monoclonal antibody is commercially available.
[0050] In the present invention, the silver nanoparticle-IgM antibody-PEG complex (AgNPs-Ab-PEG) comprises silver nanoparticles, IgM antibodies loaded on the surface of the silver nanoparticles, and PEG (polyethylene glycol) that encapsulates the silver nanoparticles and the IgM antibodies. In the present invention, the IgM antibodies and the silver nanoparticles are preferably combined by physical adsorption, and the binding principle is the electrostatic and hydrophobic interaction between the protein molecules and the surface layer of the silver nanoparticle colloid. In the present invention, the PEG plays a role in blocking the remaining active sites, so that the silver nanoparticle-IgM antibody has better stability and reduces non-specific adsorption.
[0051] In the present invention, the particle size of the silver nanoparticles is preferably 1 to 100 nm, more preferably 25 to 50 nm. The present invention has no special requirements on the source of the silver nanoparticles, and commercially available silver nanoparticles in the art or self-prepared silver nanoparticles can be used. When self-prepared, the present invention preferably adopts a chemical reduction method for preparation, and the reducing agent used is preferably sodium citrate and tannic acid.
[0052] In the present invention, the IgM antibody is preferably goat anti-mouse IgM antibody, and the source is preferably commercially available. In the present invention, the molecular weight M of the PEG is W It is preferably 2,000 to 10,000, more preferably 5,000.
[0053] In the present invention, the method for preparing the silver nanoparticle-IgM antibody-PEG complex preferably comprises the following steps:
[0054] mixing the silver nanoparticles with the IgM antibody solution and incubating the mixture to obtain an incubation solution;
[0055] PEG was added to the obtained incubation solution to block the remaining active sites, thereby obtaining a silver nanoparticle-IgM antibody-PEG complex.
[0056] In the present invention, the incubation time is preferably 4-37°C, the time is preferably 0.5-2.0 hours, and more preferably 1 hour. The present invention preferably performs the incubation in a centrifuge tube, and before the incubation, the present invention preferably first uses a BSA solution to block the centrifuge tube to avoid nonspecific binding of nanoparticles and antibody molecules on the tube wall.
[0057] In the present invention, the mass ratio of the silver nanoparticles to PEG is preferably 0.8 to 2.12:1, more preferably 1 to 2:1. In the present invention, after adding PEG, the present invention preferably performs multiple centrifugation-washing-resuspending operations on the obtained product to completely remove excess unbound substances, and the centrifugation rate is preferably 12500r / min and the temperature is preferably 4°C. In the present invention, the obtained silver nanoparticle-IgM antibody-PEG complex is preferably stored at 4°C.
[0058] In the present invention, the H2O2 is preferably provided in the form of a solution. The concentration of the H2O2 solution is divided into two types. One is a 0.1-0.8 mol / L H2O2 solution, which is used to etch the AgNPs in the silver nanoparticle-IgM antibody-PEG complex into Ag + ; A 2-10 mol / L H2O2 solution is used to react with the platinum-copper bimetallic alloy nanozyme to produce O2 gas.
[0059] In the present invention, the particle size of the platinum-copper bimetallic alloy nanozyme (PtCuNCs) is preferably 10 to 30 nm, more preferably 20 nm. In the present invention, the molar ratio of Pt to Cu in the platinum-copper bimetallic alloy nanozyme is preferably 1 to 5:1, more preferably 1 to 3:1, and further preferably 1:1.
[0060] In the present invention, the method for preparing the platinum-copper bimetallic alloy nanozyme preferably comprises the following steps:
[0061] The soluble platinum source, the soluble copper source and the stabilizer solution are heated and mixed to obtain a mixed solution;
[0062] The mixture is mixed with a reducing agent to carry out a reduction reaction to obtain a platinum-copper bimetallic alloy nanozyme.
[0063] In the present invention, the soluble platinum source is preferably K2PtCl6, and the soluble copper source is preferably CuSO4; in the present invention, the soluble platinum source and the soluble copper source are preferably provided in the form of a mixed solution of a platinum source and a copper source, and the total molar concentration of the soluble platinum source and the soluble copper source in the mixed solution is preferably 5 to 10 mmol / L.
[0064] In the present invention, the stabilizer is preferably one or more of polyvinyl pyrrolidone (PVP), sodium citrate and cetyl trimethyl ammonium bromide (CTAB), more preferably polyvinyl pyrrolidone. In the present invention, the concentration of the stabilizer solution is preferably 0.8 to 2 mg / mL, more preferably 1 mg / mL; the volume ratio of the polyvinyl pyrrolidone solution to the mixed solution of the platinum source and the copper source is preferably 1 to 2.5:1.
[0065] In the present invention, the temperature of the heating and mixing is preferably 100 to 150° C., more preferably 110 to 130° C.; in the present invention, the heating and mixing is preferably carried out under vigorous stirring conditions.
[0066] In the present invention, the reducing agent is preferably ascorbic acid (AA); in the present invention, the ascorbic acid is preferably provided in the form of a solution, the concentration of the ascorbic acid solution is preferably 50-100 mmol / L, more preferably 60-80 mmol / L, and the volume ratio of the ascorbic acid solution to the mixed solution of the platinum source and the copper source is preferably 1:0.8-2.6, more preferably 1:1-2. In the present invention, the temperature of the reduction reaction is preferably 100-150°C, more preferably 110-130°C; the time is preferably 1.5-3h, more preferably 2h. The color of the solution gradually changes to brown-black, indicating the successful synthesis of PtCuNCs.
[0067] After the reduction reaction, the present invention preferably centrifuges and washes the obtained reduction reaction solution to remove excess PVP; the present invention preferably redisperses the obtained PtCuNCs in water and stores them at 4 to 37°C.
[0068] In the present invention, the dye is preferably one or more of indigo carmine dye, woad dye and Tyrian red violet dye.
[0069] In the present invention, the microfluidic chip comprises a sample chamber, a reaction chamber and a strip microchannel which are connected in sequence. In the present invention, the structural schematic diagram of the microfluidic chip is as shown in Figure 1 As shown in the actual picture Figure 2 shown.
[0070] In the present invention, the microfluidic chip preferably includes a bottom plate and a top plate attached to the bottom plate;
[0071] The bottom plate comprises a sample chamber, a first reaction chamber, a second reaction chamber and a strip-shaped microchannel which are connected in sequence; the strip-shaped microchannel is in a "snake" shape.
[0072] The top plate includes a first sample addition port, a second sample addition port, a third sample addition port, a first gas outlet and a second gas outlet; the first sample addition port is located above the sample chamber, for adding a mixture of platinum-copper bimetallic alloy nanozyme and a sample solution to be tested; the second sample addition port is located above the first reaction chamber, for adding H2O2; the third sample addition port is located above the second reaction chamber, for adding a dye; the first gas outlet is located above the first reaction zone or the second reaction zone; the second gas outlet is located above the outlet of the strip microchannel.
[0073] In the present invention, the diameter of the strip microchannel is preferably 0.2-0.3 mm, the length is preferably 45-50 cm, and the depth is preferably 0.2-0.3 mm; the diameter of the sample chamber is 7-8 mm, the diameter of the first reaction chamber is 5-6 mm, and the diameter of the second reaction chamber is 5-6 mm;
[0074] The diameters of the first sample adding port, the second sample adding port, the third sample adding port, the first gas outlet and the second gas outlet are independently 0.8-1 mm.
[0075] In the present invention, the length, width and thickness of the microfluidic chip are preferably 30 mm, 90 mm and 2 mm, respectively.
[0076] In the present invention, the material of the bottom plate and the top plate is preferably polymethyl methacrylate.
[0077] The present invention provides a method for detecting AFB1 based on signal enhancement distance sensing, comprising the following steps:
[0078] Adding AFB1 monoclonal antibody and a sample solution to be tested to a solid phase carrier coated with AFB1-BSA, performing a first incubation, washing away unbound substances, and obtaining a first incubation product;
[0079] adding a silver nanoparticle-IgM antibody-PEG complex to the first incubation product, performing a second incubation, and washing away unbound substances to obtain a second incubation product;
[0080] adding the first H2O2 solution to the second incubation product to perform an etching reaction to obtain a pre-reaction solution;
[0081] The pre-reaction solution is mixed with the platinum-copper bimetallic alloy nanozyme, the resulting mixed solution is added to the sample chamber of the microfluidic chip, the second H2O2 solution and the dye are added to the reaction chamber of the microfluidic chip, the sample addition port is sealed, the microfluidic chip is shaken, the enzyme catalyzed reaction is performed, and the movement distance of the dye in the strip microchannel within a fixed time is measured;
[0082] The content of AFB1 in the sample solution to be tested is obtained according to the dye movement distance and a predetermined standard curve; the standard curve is a fitting curve of AFB1 concentration and dye movement distance.
[0083] In the present invention, the preparation methods of the solid phase carrier coated with AFB1-BSA, the silver nanoparticle-IgM antibody-PEG complex, and the platinum-copper bimetallic alloy nanozyme are as mentioned above and will not be repeated here.
[0084] The present invention adds AFB1 monoclonal antibody and a sample solution to be tested to a solid phase carrier coated with AFB1-BSA, performs a first incubation, washes away unbound substances, and obtains a first incubation product. In the present invention, the sample to be tested is preferably food, specifically preferably corn, rice or peanut.
[0085] In the present invention, the concentration of the AFB1 monoclonal antibody is preferably 0.8228 μg / mL; the volume ratio of the AFB1 monoclonal antibody to the sample solution to be tested is preferably 0.8-1.6:1, more preferably 1:1. In the present invention, the temperature of the first incubation is preferably 20-40°C, more preferably 37°C, and the time is preferably 20-60 min, more preferably 30-40 min. The present invention preferably uses PBST buffer solution to wash away the unbound substances, and the PBST buffer solution contains Tween-20 with a volume concentration of 0.05%, pH = 7.4. In the present invention, the number of times of washing away the unbound substances is preferably 3 times.
[0086] After obtaining the first incubation product, the present invention adds a silver nanoparticle-IgM antibody-PEG complex to the first incubation product, performs a second incubation, washes away unbound substances, and obtains a second incubation product. In the present invention, the silver nanoparticle-IgM antibody-PEG complex is preferably added in the form of an aqueous dispersion, and the concentration of the silver nanoparticle-IgM antibody-PEG complex aqueous dispersion is preferably 20 μg / mL; in the present invention, the volume ratio of the silver nanoparticle-IgM antibody-PEG complex aqueous solution to the sample solution to be tested is preferably 0.8 to 1.6:1, and more preferably 1 to 1.5:1.
[0087] In the present invention, the temperature of the second incubation is preferably 20-40°C, more preferably 37°C; the time is preferably 20-60 min, more preferably 30-40 min. The present invention preferably uses a PBST buffer solution to wash away the unbound substances, wherein the PBST buffer solution contains Tween-20 with a volume concentration of 0.05%, and pH = 7.4. In the present invention, the number of times of washing away the unbound substances is preferably 3 times.
[0088] After obtaining the second incubation product, the present invention adds the first H2O2 solution to the second incubation product to perform an etching reaction to obtain a pre-reaction solution. In the present invention, the concentration of the first H2O2 solution is preferably 0.1 to 0.8 mol / L, more preferably 0.2 to 0.6 mol / L; the volume ratio of the first H2O2 solution to the sample solution to be tested is preferably 0.8 to 1.6:1, more preferably 1:1.
[0089] In the present invention, the temperature of the etching reaction is preferably 20 to 40° C., more preferably 25 to 37° C.; the time is preferably 0 to 10 min, more preferably 1 to 5 min.
[0090] After obtaining the pre-reaction liquid, the present invention mixes the pre-reaction liquid with the platinum-copper bimetallic alloy nanozyme, adds the resulting mixed solution to the sample chamber of the microfluidic chip, adds the second H2O2 solution and the dye to the reaction chamber of the microfluidic chip, closes the sample addition port, shakes the microfluidic chip, performs an enzyme-catalyzed reaction, and measures the movement distance of the dye in the strip microchannel within a fixed time. In the present invention, the platinum-copper bimetallic alloy nanozyme is preferably added in the form of a solution, the concentration of the platinum-copper bimetallic alloy nanozyme solution is preferably 1 to 2.5 μmol / L, and the concentration of the platinum-copper bimetallic alloy nanozyme solution is determined by the content of the platinum element; the volume ratio of the pre-reaction liquid to the platinum-copper bimetallic alloy nanozyme solution is preferably 0.8 to 1.6:1, more preferably 1:1. In the present invention, the platinum-copper bimetallic alloy nanozyme is preferably added in the form of a buffer solution, and the buffer solution is preferably a boric acid buffer solution; the pH value of the platinum-copper bimetallic alloy nanozyme buffer solution is preferably 9. In the present invention, when pH = 9, the ability of the platinum-copper bimetallic alloy nanozyme to catalyze the decomposition of H2O2 is the greatest.
[0091] In the present invention, the concentration of the second H2O2 solution is preferably 2-10 mol / L, more preferably 4-8 mol / L; the volume ratio of the mixed solution, the second H2O2 solution and the dye is preferably 1:1-2.2:2-2.6, more preferably 1:2:2.
[0092] In the present invention, the second H2O2 solution is preferably added to the first reaction chamber of the microfluidic chip, and the dye is preferably added to the second reaction chamber of the microfluidic chip. In the present invention, during the enzyme catalytic reaction, H2O2 generates O2 gas, which pushes the dye to move forward along the strip microchannel. In the present invention, the fixed time for measuring the moving distance of the dye in the strip microchannel within the fixed time is preferably 10 to 30 minutes, more preferably 10 to 15 minutes.
[0093] After obtaining the dye movement distance, the present invention obtains the content of AFB1 in the sample solution to be tested according to the dye movement distance and a predetermined standard curve; the standard curve is a fitting curve of AFB1 concentration and dye movement distance. In the present invention, the method for obtaining the standard curve preferably includes the following steps:
[0094] Provide gradient AFB1 standard solutions with known concentrations;
[0095] The AFB1 standard solution of known concentration is used as the sample solution to be tested, a pre-reaction solution is prepared according to the above method, and the pre-reaction solution is mixed with the platinum-copper bimetallic alloy nanozyme, the obtained mixed solution is added to the sample chamber of the microfluidic chip, the second H2O2 solution and the dye are added to the reaction chamber of the microfluidic chip, the sample addition port is sealed, the microfluidic chip is shaken, the enzyme catalyzed reaction is performed, and the movement distance of the dye in the strip microchannel within a fixed time is measured to obtain the dye movement distance corresponding to the AFB1 solutions of different concentrations;
[0096] The concentration of AFB1 solution is used as the horizontal axis and the distance of dye movement is used as the vertical axis to obtain the fitting curve, which is the standard curve.
[0097] In the present invention, the detection limit of AFB1 is 9 pg / mL, and the detection range is 0 to 50 ng / mL. As a specific embodiment of the present invention, the standard curve is y=120.639 / [1+(x / 157.852)-0.584]+0.652, and the correlation coefficient R 2 is 0.9965.
[0098] In the present invention, the flow chart of detecting AFB1 based on signal enhancement distance sensing is as follows: Figure 3 shown.
[0099] The method and kit for detecting AFB1 based on signal enhancement distance sensing provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the scope of protection of the present invention.
[0100] In the following examples, goat anti-mouse IgM antibody was purchased from Sangon Biotech (Shanghai) Co., Ltd. (Shanghai, China); AFB1-BSA conjugate and AFB1 monoclonal antibody (AFB1-primary antibody, denoted as AFB1mAb) were provided by China Agricultural University (Beijing, China); corn starch samples were purchased from the supermarket on campus of Gannan Normal University.
[0101] Example 1
[0102] ①Synthesis of silver nanoparticles
[0103] First, weigh 0.1471g sodium citrate and 0.1701g tannic acid, add them to a flask pre-filled with 100mL water, and stir and heat to 110℃. Then quickly add 1mL 25mM AgNO3 solution, and observe that the color of the solution immediately changes to bright yellow. Continue heating for 15 minutes and then stop heating. When the temperature drops to 90℃, add sodium citrate solution (100μL, 25mM), tannic acid solution (250μL, 2.5mM) and AgNO3 solution (250μL, 25mM) in sequence, and continue to react for 30 minutes. The sample is purified by centrifugation at 4℃, 12500r / min and washing twice to remove excess sodium citrate and tannic acid, and redispersed in sodium citrate (2mM, pH=8.0), and stored at 4℃ for use.
[0104] ②Synthesis of silver nanoparticles-IgM antibody-PEG complex (AgNPs-Ab-PEG)
[0105] First, 1 mL of 1% BSA was used to pre-soak and seal the centrifuge tube wall to prevent nonspecific binding of nanoparticles and antibody molecules on the tube wall. Then, AgNPs (10 μg / mL, 800 μL) were added to the IgM antibody solution (20 μg / mL, 100 μL) and incubated at 4°C for 1 hour. PEG (M W =5000, 20 μg / mL, 100 μL) was used to block the remaining active sites, so that the antibody-silver nanoparticle complex has better stability and reduces nonspecific adsorption. The synthesized product was centrifuged at 12500 r / min and 4°C, and washed / resuspended for multiple times to completely remove excess unbound substances, and finally stored at 4°C for use.
[0106] ③Synthesis of platinum-copper bimetallic alloy nanozymes (PtCuNCs)
[0107] 5 mL of PVP solution (1 mg / mL) and 2 mL of K2PtCl6·6H2O solution and CuSO4·5H2O solution (molar ratio of 5:5) with a total concentration of 10 mM were added to the colorimetric tube in sequence, stirred vigorously and heated to 110°C. Subsequently, 1 mL of AA solution (100 mM) was added, and the reaction mixture was stirred and heated for 2 hours to ensure that all metal precursors were completely reduced and the excess AA was completely decomposed. Finally, the color of the solution was observed to gradually change to brown-black, indicating the successful synthesis of PtCuNCs. The sample was purified by centrifugation at 12000 r / min and washed 3 times to remove excess PVP, and was redispersed in water and stored at 4°C.
[0108] ④ Fabrication of microfluidic chips
[0109] Prepared as follows Figure 1 The microfluidic chip shown.
[0110] First, the plane graphics of the chip are drawn by CorelDraw software, which mainly includes a base plate and a cover plate. In order to facilitate sample loading, the diameter of the first sample slot is designed to be 7mm, the diameter of the second and third slots are both 5mm, the length, width and thickness of the chip are designed to be 30mm, 90mm and 2mm respectively, and the diameter of the sample loading hole is designed to be 1mm, and the diameter of the serpentine channel is designed to be 0.3mm. The polymethyl methacrylate (PMMA) material is cut by laser cutting technology, and then the two cut plates are washed and ultrasonically treated, then dried at 60°C, and finally blown dry with N2. Next is the assembly of the chip. First, the cover plate and the base plate are aligned and fixed. In order to ensure the airtightness of the chip, the two plates need to be glued and bonded tightly by hot bonding and method. When the temperature reaches 110°C, the plate is placed on a rubber sheet for hot pressing (1MPa, 3 minutes), and finally the manufactured chip is taken out and cooled for use. The actual picture of the manufactured microfluidic chip is as follows Figure 2 shown.
[0111] Example 2
[0112] Based on the signal enhancement distance sensing detection AFB1, the method is as follows:
[0113] First, a competitive immune reaction was performed. 100 μL AFB1-BSA was added to a 96-well plate and incubated at 4°C overnight. After washing three times with PBST (containing 0.05% Tween-20, pH = 7.4), it was blocked with 150 μL of 3wt% BSA (PBS) and incubated at 37°C for 2 hours. Then it was washed three times with PBST, and 50 μL of AFB1-primary antibody and 50 μL of different concentrations of AFB1 standard solution / sample solution were added to each well, and incubated at 37°C for 30 minutes for competitive reaction. After washing three times with PBST, 100 μL of prepared AgNPs-Ab-PEG was added to each well, and the reaction continued at 37°C for 30 minutes, and washed three times with PBST. Subsequently, 50 μL 0.1M H2O2 was added as an etchant to etch the AgNPs into Ag + , and obtain the pre-reaction solution for standby use.
[0114] AFB1 was then detected using a microfluidic chip. First, a 2μM PtCuNCs concentration was prepared using a boric acid buffer with a pH of 9 to ensure the pH of the reaction system. The pre-reaction solution was pipetted and mixed evenly with the PtCuNCs solution in a 1:1 ratio. Then 5μL of the mixture was pipetted and added to the sample chamber in the microfluidic chip. 10μL H2O2 (10M) and 10μL indigo carmine dye were added to the corresponding reaction chambers in sequence. All sample ports were sealed with a sealing film, and the chip was held at the corner and gently shaken. The reaction solution in the chip came into contact and generated gas, causing the dye to move forward along the channel. The distance the dye moved within 10 minutes was recorded.
[0115] ① In order to verify whether the signal-enhanced distance sensing platform constructed above has the feasibility of detecting AFB1, the dye movement distance in the microfluidic chip in the presence of different concentrations of AFB1 solution was analyzed and studied. The results are as follows: Figure 4 shown. Figure 4 The left figure in A shows the distance that the dye moves in the chip channel in 10 minutes under different concentrations of AFB1 solution, and the right figure is a colorimetric diagram of AFB1 detection using conventional methods; Figure 4 B in the figure is the change of the dye movement distance in the chip over time (recorded every 2 minutes, measured in parallel 3 times).
[0116] It can be seen that when the AFB1 concentration in the sample is 0 ng / mL, after 10 minutes of reaction, the dye migration distance in the chip is only 0.2 cm; when the AFB1 concentration increases to 5 ng / mL and 20 ng / mL, the dye migration distance in the chip increases to 16.4 cm and 27.3 cm respectively; and when the AFB1 concentration further increases to 40 ng / mL, the dye migration distance in the chip is the longest, which is 38.1 cm. The above results show that the higher the AFB1 concentration in the sample, the longer the dye migration distance, that is, the dye migration distance is proportional to the AFB1 concentration.
[0117] In addition, in order to verify the advantages of the signal-enhanced distance sensing scheme, the conventional colorimetric method was also verified to determine the same concentration of AFB1. This method uses HRP-IgM to trigger the colorimetric reaction process. The specific method is as follows: First, a competitive immune reaction was performed, and 100 μL AFB1-BSA was added to a 96-well plate and incubated overnight at 4°C. After washing 3 times with PBST (containing 0.05% Tween-20, pH = 7.4), it was blocked with 150 μL of 3wt% BSA (PBS) and incubated at 37°C for 2 hours. Then it was washed 3 times with PBST, and 50 μL AFB1-primary antibody and 50 μL of different concentrations of AFB1 standard solution / sample solution were added to each well, incubated at 37°C for 30 minutes, and a competitive reaction was performed. After washing 3 times with PBST, 100 μL of the prepared AgNPs-Ab-PEG was added to each well, and the reaction continued at 37°C for 30 minutes, and washed 3 times with PBST. Then, 100 μL of ELISA colorimetric solution (50 μL of solution A, the main substance of which is H2O2, and 50 μL of solution B, the main substance of which is TMB) was added to each well and incubated at room temperature for 10 min, causing the color to change from colorless to blue.
[0118] Depend on Figure 4 As can be seen from A in the figure, although the color of the solution gradually becomes lighter with the increase of AFB1 concentration, it is difficult to distinguish different samples one by one with the naked eye. For example, it is difficult to distinguish the blank sample from the 5ng / mL AFB1 sample, and it is difficult to distinguish the 20ng / mL AFB1 sample from the 40ng / mL AFB1 sample. The above experimental results show that the present invention has successfully developed a signal-enhanced distance sensing platform with good naked eye resolution, which can be used to analyze low concentration levels of AFB1.
[0119] ② The target AFB1 was detected using the above signal-enhanced distance sensing platform. The concentration of AFB1 was 0-50 ng / mL. The signal-enhanced distance sensing platform detected the dye movement distance of different concentrations of AFB1 and the fitting curve equation was as follows: Figure 5 As shown. It can be seen that when the concentration of AFB1 gradually increases, the distance the dye moves in the microfluidic chip also increases. Even if it is a trace level of AFB1, it can be easily quantitatively detected by the naked eye. The dye movement distance is positively correlated with the AFB1 concentration, and the four-parameter fitting curve equation is: y = 120.639 / [1+(x / 157.852)-0.584]+0.652, and the correlation coefficient R 2 The detection limit (LOD) is 9pg / mL, which meets the limit requirements of different countries.
[0120] The analytical performance of the detection method provided by the present invention is compared with existing methods for detecting AFB1 such as fluorescence, electrochemiluminescence, and colorimetry. The comparison results are shown in Table 1.
[0121] Table 1 Comparison of the detection method of the present invention with the previously reported AFB1 detection method
[0122] Detection Methods Detection range Detection limit <![CDATA[AFB1 sample]]> References Fluorescence method 1–1000 pg / mL 0.492pg / mL Peanut Oil [1] Electrochemical method 0.001~30 ng / mL 0.8pg / mL corn [2] Electrochemiluminescence 0.005–10 ng / mL 0.005ng / mL Rice [3] ELISA 0.01~20 ng / mL 0.009ng / mL Peanut milk, soy milk [4] Ratiometric fluorescence 0~3.33 ng / mL 0.08ng / mL bulb [5] Colorimetry 0.2~8.0ng / g 0.08ng / g Beans [6] Distance Sensor 0~50 ng / mL 9pg / mL corn The present invention
[0123] [1]Wang Q., Zhao F., Yang Q., et al.Graphene oxide quantum dots basednanotreeilluminates AFB1:Dual signal amplified aptasensor detection AFB1[J].SensorsandActuators B:Chemical,2021,345:130387.
[0124] [2]Li
[0126] [3]Tian D., Wang J., Zhuang Q., et al. An electrochemiluminescence biosensor based on Graphitic carbon nitride luminescence quenching for detection of AFB1[J].
[0127] Food Chemistry,2023,404:134183.
[0128] [4]Xu Z.,Long L.-L.,Chen Y.-Q.,et al.A nanozyme-linked immunosorbent assay based on metal-organic frameworks(MOFs) for sensitive detection ofaflatoxinB1[J].Food chemistry,2021,338:128039.
[0129] [5] Dou
[0130] [6]Lu L.,Yu R.,Zhang L.AFB1 colorimetric aptamer sensor for the detection ofAFB1 in ten different kinds of miscellaneous beans based on goldnanoparticlesand smartphone imaging[J].Food Chemistry,2023,421:136205.
[0131] The comparison results show that the detection method provided by the present invention has certain advantages in terms of detection range and sensitivity. Therefore, the present invention successfully overcomes the disadvantage of low sensitivity of traditional detection of small molecule targets, and also has the advantages of easy carrying and rapid reading of detection results.
[0132] Example 3Ag + Research on regulatory ability
[0133] Metal Ag + It can effectively inhibit the catalase activity of PtCuNCs, so it is necessary to further explore the effect of different concentrations of Ag + Catalase activity of PtCuNCs under different conditions.
[0134] Dye migration distance in microfluidic chip and Ag + The linear graph of concentration is Figure 6 As shown. It can be seen that when there is no Ag+ When Ag is added, the catalytic ability of PtCuNCs is not inhibited, that is, its catalase activity is the strongest at this time, so the dye moves the longest distance in the microfluidic chip. + As the concentration increases from 0 to 100 nM, the catalase activity of PtCuNCs is inhibited, its catalytic ability gradually decreases, and the dye migration distance also becomes shorter. In this range, the dye migration distance is similar to that of Ag. + The concentration showed a good linear relationship, the linear regression equation was y = -0.3098x + 46.862, and the correlation coefficient R 2 =0.9972.
[0135] Example 4 Specificity Experiment
[0136] In order to evaluate the specificity of the signal-enhanced sensing platform of the present invention in detecting AFB1, several structural analogs of AFB1 such as aflatoxin B2 (AFB2), aflatoxin G1 (AFG1) and other fungal toxins such as ochratoxin (OTA) and deoxynivalenol (DON) were selected as interfering substances (added at 100 ng / mL) and tested under the same conditions as in Example 2. The test results are as follows: Figure 7 shown.
[0137] It can be seen that when the concentration of AFB1 is 50 ng / mL, the dye movement distance in the microfluidic chip is 42.1 cm. When other interfering substances with higher concentrations (100 ng / mL) are added, the dye movement distance is only 0.5 to 2.5 cm, which is much lower than the dye movement distance when detecting AFB1. The results show that the signal enhancement sensing platform proposed in the present invention has good specificity for the detection of AFB1.
[0138] Example 5 Detection of actual samples
[0139] First, weigh 4.0g corn starch and place it in a tube, then add 10mL methanol solution (80%, V / V). The mixture is shaken vigorously and ultrasonically treated for 0.5 hours, then centrifuged at 12000r / min for 15 minutes. The obtained supernatant is first filtered with filter paper, then filtered with a 0.22μm syringe, and finally diluted with PBS (pH=7.4) to a certain multiple, and stored at 4°C for actual sample analysis.
[0140] AFB1 was not detected in corn starch. Different concentrations of AFB1 standard solutions were added to the corn extract sample solution to form different spiked samples with final concentrations of 2, 5, 10 and 20 ng / mL. The spiked samples were detected using the method of Example 2, and the recovery was calculated. The results are shown in Table 2.
[0141] Table 2 Recovery of AFB1 in corn starch samples
[0142]
[0143] It can be seen that the spiked recovery range and RSD range of AFB1 in corn starch are between 97.0% and 106.5% and 4.8% and 6.6%, respectively, indicating that the signal-enhanced distance sensing has reliable accuracy and precision. Therefore, the sensing platform based on the signal-enhanced sensing strategy can be used for the quantitative detection of AFB1 in actual samples. Compared with the traditional colorimetric output, the detection results are intuitive and visualized, and the quantitative detection of low-concentration targets can be achieved with the naked eye.
[0144] In summary, based on the traditional competitive immunoassay, the present invention uses a bimetallic alloy nanozyme with high catalytic activity to develop a distance sensing platform based on a signal enhancement strategy, which realizes the visual quantitative detection of AFB1 in corn. The results show that the distance sensing platform has the following advantages: the dye movement distance in the chip is well correlated with the AFB1 concentration in a wide detection range (0-50ng / mL), and is positively correlated. Secondly, unlike the signal suppression output mode, the reversal of this output mode greatly improves the sensitivity of visual quantitative detection by the naked eye. Under optimal conditions, the detection limit is as low as 9pg / mL. In addition, the present invention also has the advantages of integrating sample addition, detection, and output, as well as the advantages of strong portability, low cost, and simple operation. In general, the signal enhancement distance sensing platform provided by the present invention has extremely high application value for places outside laboratories, especially food safety detection in resource-scarce areas.
[0145] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A method for detecting AFB 1 Microfluidic chip detection kit, It is characterized in that Including surface coated with AFB 1 -BSA solid support; AFB 1 Monoclonal antibody; Silver nanoparticle-IgM antibody-PEG complex; H 2 O 2 ; Platinum-copper bimetallic alloy nanozyme; dye; microfluidic chip; The microfluidic chip comprises a sample chamber, a reaction chamber and a strip-shaped microchannel which are connected in sequence.
2. The method for detecting AFB according to claim 1. 1 Microfluidic chip detection kit, It is characterized in that Also included is BSA solution and PBST wash solution.
3. AFB based on signal enhancement distance sensing detection 1 method, It is characterized in that The following steps are involved: AFB 1 -BSA solid phase carrier with AFB 1 The monoclonal antibody and the sample solution to be tested are first incubated, and unbound substances are washed away to obtain a first incubation product; adding a silver nanoparticle-IgM antibody-PEG complex to the first incubation product, performing a second incubation, and washing away unbound substances to obtain a second incubation product; Add the first H 2 O 2 solution, performing etching reaction to obtain a pre-reaction solution; The pre-reaction solution was mixed with the platinum-copper bimetallic alloy nanozyme, and the resulting mixture was added to the sample chamber of the microfluidic chip. 2 O 2 The solution and dye are added to the reaction chamber of the microfluidic chip, the sample addition port is sealed, the microfluidic chip is shaken, the enzyme catalyzed reaction is performed, and the movement distance of the dye in the strip microchannel within a fixed time is measured; The AFB content in the sample solution to be tested can be obtained based on the dye migration distance and the predetermined standard curve. 1 The standard curve is AFB 1 Fitting curve of concentration and dye migration distance.
4. The method according to claim 3, It is characterized in that The surface is coated with AFB 1 -A method for preparing a solid phase carrier of BSA, comprising the following steps: AFB 1 -BSA is loaded into the solid phase carrier, incubated, unbound substances are washed away, and unbound sites on the surface of the solid phase carrier are blocked to obtain a surface coated with AFB 1 -BSA solid support.
5. The method according to claim 3, It is characterized in that The method for preparing the silver nanoparticle-IgM antibody-PEG complex comprises the following steps: mixing the silver nanoparticles with the IgM antibody solution and incubating the mixture to obtain an incubation solution; PEG was added to the obtained incubation solution to block the remaining active sites, thereby obtaining a silver nanoparticle-IgM antibody-PEG complex.
6. The method according to claim 3, It is characterized in that The particle size of the platinum-copper bimetallic alloy nanozyme is 10 to 30 nm.
7. The method according to claim 3 or 6, It is characterized in that The preparation method of the platinum-copper bimetallic alloy nanozyme comprises the following steps: The soluble platinum source, the soluble copper source and the stabilizer solution are heated and mixed to obtain a mixed solution; The mixture is mixed with a reducing agent to carry out a reduction reaction to obtain a platinum-copper bimetallic alloy nanozyme.
8. The method according to claim 3, It is characterized in that The first incubation temperature is 20-40°C and the time is 20-60 minutes; The second incubation temperature is 20-40°C and the time is 20-60 minutes; The etching reaction time is 0 to 10 minutes.
9. The method according to claim 3, It is characterized in that The fixing time is 10 to 30 minutes.
10. The method according to claim 3, It is characterized in that The AFB 1 The detection limit is 9pg / mL and the detection range is 0~50ng / mL.
